Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Imdevimab Emergency use authorization Experimental Antiviral Nov/23/2020 Nov/24/2020 0
Casirivimab Emergency use authorization Experimental Antiviral Nov/23/2020 Nov/24/2020 0
ChAdOx1 nCoV-19 Potential treatment - clinical evidence Experimental Vaccine Nov/18/2020 Nov/24/2020 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Nov/14/2020 Nov/27/2020 0
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/13/2020 Nov/24/2020 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/13/2020 Nov/24/2020 0
Baicalein Potential treatment - pre-clinical evidence Natural product Antiviral Nov/13/2020 Nov/27/2020 0
MW05/LALA Potential treatment - pre-clinical evidence Experimental Antiviral Nov/13/2020 Nov/27/2020 0
Baricitinib Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/13/2020 Nov/27/2020 0
Remdesivir Approved by FDA Experimental Antiviral Nov/12/2020 Nov/24/2020 0